The popularity of copyright’s blockbuster initially fueled a surge for the drug industry, but recent developments present a uncertain scenario for shareholders. Generic versions are eating into earnings, and https://inesvwjf009393.blog-eye.com/41526540/the-blue-pill-and-pharma-a-risky-bet